EUVIMEDEUVIMED entdecken
Crossref

A Simple and Sensitive LC‐MS/MS Method for the Determination of Mobocertinib and Its Metabolite Desmethyl‐Mobocertinib in Human Plasma and Its Application to Clinical Pharmacokinetic Study

Fan Tang iD, Xiaoli Hou, Jiajie Chen, Yasen Cao, Yixia Wang, Hong Cheng iD

Biomedical Chromatography · 2025

DOI: 10.1002/bmc.6063 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomedical Chromatography, 2025. Verfasst von Fan Tang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Jingjiang People's Hospital Affiliated to Yangzhou University, Jingjiang, Jiangsu Province, China. Hauptthemen laut MEDLINE: Tandem Mass Spectrometry. Die Arbeit nennt 14 Literaturangaben. Gefördert von: Qinglan Project of Jiangsu Province of China, Project of Outstanding Yong Backbone Teacher at Yangzhou Polytechnic College.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mobocertinib is a potent selective tyrosine kinase inhibitor approved for the treatment of non–small cell lung cancer with activating EGFR exon 20 insertions. The aim of this study was to develop a procedure for liquid chromatography tandem mass spectrometry (LC‐MS/MS) for the determination of mobocertinib and its metabolite desmethyl‐mobocertinib in human plasma. The human plasma samples were precipitated with acetonitrile and analyzed using a Waters ACQUITY BEH C 18 column coupled to a triple quadrupole mass spectrometer. Separation was executed using the acetonitrile–0.1% formic acid solution with gradient elution, at a flow rate of 0.4 mL/min. Mobocertinib and desmethyl‐mobocertinib were monitored by multiple reaction monitoring (MRM) with m / z 586.5 > 72.2 and 572.4 > 473.2, respectively. The procedure demonstrated excellent linearity ( r > 0.997) within the concentration range of 0.1–200 ng/mL for both analytes. Precision in relative standard deviation was < 9.37% for mobocertinib and < 12.03% for desmethyl‐mobocertinib. Accuracy in relative error was within −7.23% to 9.18% for mobocertinib and −2.78% to 9.87% for desmethyl‐mobocertinib. Extraction recovery was > 80% for both analytes. The validated LC‐MS/MS method was successfully applied to the pharmacokinetic study of mobocertinib and desmethyl‐mobocertinib in healthy human volunteers with K 2 EDTA as anticoagulant after a single dose of mobocertinib (160 mg).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tandem Mass SpectrometryHumansChromatography, LiquidReproducibility of ResultsLinear ModelsLimit of DetectionSensitivity and SpecificityMaleLiquid Chromatography-Mass SpectrometryAniline CompoundsIndolesPyrimidines

Stichwörter der Autor:innen

LC‐MS/MSclinical pharmacokineticsdesmethyl‐mobocertinibmobocertinib

Substanzen

mobocertinibAniline CompoundsIndolesPyrimidines

Autor:innen und Institutionen

  • Jingjiang People's Hospital Affiliated to Yangzhou University, Jingjiang, Jiangsu Province, China.
  • Department of Medical Science, Yangzhou Polytechnic College, Yangzhou, Jiangsu Province, China.
  • Yangzhou University Medical College, Jiangsu Key Laboratory of Experimental & Translational Non-coding RNA Research, Institute of Translational Medicine, Yangzhou University, Yangzhou, Jiangsu Province, China.

ORCID-Profile: Fan Tang, Hong Cheng

Förderung

  • Qinglan Project of Jiangsu Province of China
  • Project of Outstanding Yong Backbone Teacher at Yangzhou Polytechnic College

Zitieren

APA

Tang, F., Hou, X., Chen, J., Cao, Y., Wang, Y., & Cheng, H. (2025). A Simple and Sensitive LC‐MS/MS Method for the Determination of Mobocertinib and Its Metabolite Desmethyl‐Mobocertinib in Human Plasma and Its Application to Clinical Pharmacokinetic Study. Biomedical Chromatography. https://doi.org/10.1002/bmc.6063

Vancouver

Tang F, Hou X, Chen J, Cao Y, Wang Y, Cheng H. A Simple and Sensitive LC‐MS/MS Method for the Determination of Mobocertinib and Its Metabolite Desmethyl‐Mobocertinib in Human Plasma and Its Application to Clinical Pharmacokinetic Study. Biomedical Chromatography. 2025. doi:10.1002/bmc.6063

BibTeX
@article{Tang2025,
  author = {Tang, Fan and Hou, Xiaoli and Chen, Jiajie and Cao, Yasen and Wang, Yixia and Cheng, Hong},
  title = {A Simple and Sensitive LC‐MS/MS Method for the Determination of Mobocertinib and Its Metabolite Desmethyl‐Mobocertinib in Human Plasma and Its Application to Clinical Pharmacokinetic Study},
  journal = {Biomedical Chromatography},
  year = {2025},
  doi = {10.1002/bmc.6063}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche